COMMUNIQUÉS West-GlobeNewswire

Eurobio Scientific: COMMUNIQUÉ DU 24 SEPTEMBRE 2026 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIÉTÉ
24/09/2026
COMMUNIQUÉ DU 24 SEPTEMBRE 2026 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIÉTÉ INITIEE PAR EB DEVELOPMENT PRESENTEE PAR CIC BANQUE PRESENTATRICE ET [...]
Grant of Restricted Stock Units and Warrants to Employees in Genmab
24/09/2026
Company Announcement COPENHAGEN, Denmark; September 24, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 13,794 restricted stock units and 13,331 warrants to employees of the [...]
Embark Behavioral Health Releases 2025 Outcomes Report Highlighting Measurable Improvements for Youth Mental Health
24/09/2026
Embark’s new data from more than 3,000 admissions in 2025 shows meaningful reductions in depression, anxiety and distress, along with gains in overall well-being, based on validated clinical assessments completed [...]
PROLLENIUM® Spotlights the Future of Regenerative Aesthetics at Aesthetic Next 8.0 and Chateau Prollenium Dallas
24/09/2026
RICHMOND HILL, Ontario, Sept. 24, 2026 (GLOBE NEWSWIRE) -- PROLLENIUM ® , a global leader in aesthetic innovation, brought clinical education, regenerative aesthetics and injectable technique to Dallas through two [...]
Healthcare’s Challenges Have Changed. MGMA’s Purpose Has Not.
24/09/2026
MGMA celebrates 100 years of helping medical practice leaders turn shared challenges into practical solutions Englewood, Colorado and San Antonio, Texas, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Workforce shortages. Financial [...]
Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting
24/09/2026
NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system [...]
Hyperion DeFi Supports DoubleZero Edge in Launching the Fastest Commercially Available Hyperliquid Data Feeds
24/09/2026
DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced its first initiative to bring an infrastructure team from another blockchain into the [...]
Chiropractic Founders Day highlights nearly a century of care, paves way for National Upper Cervical Care Association's continued commitment to precise patient care in spinal health
24/09/2026
SAN DIEGO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Each year, Chiropractic Founders Day is celebrated on Sept. 18, reminding the chiropractic community of the life-changing benefits it brings to millions worldwide. The date [...]
NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst
24/09/2026
DENVER, Sept. 24, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) has picked up fresh Wall Street coverage at a pivotal moment for its experimental brain-cancer pipeline. [...]
Ritedose Positioned to Support Hospitals with Reliable and Quality Albuterol Inhalation Solution, USP 0.5% (Albuterol Concentrate) Supply
24/09/2026
Ritedose expands albuterol inhalation solution production and strengthens its role as a trusted source for inhaled solutions The Company ramped up multiple albuterol inhalation solution strengths during national [...]
Easy Environmental Solutions Participates in International Roundtable at United Nations Headquarters During Climate Week NYC
24/09/2026
Company advances international relationships around localized fertilizer production, agricultural resilience, and commercial infrastructure development MANKATO, Minn. and NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- [...]
CORRECTION – Free Family Fun Night in Cedar Park: Ally Medical ER Ribbon Cutting
24/09/2026
Ally Medical ER Cedar Park hosts an evening of free food, drinks, giveaways, and kid-friendly games on October 1st. CEDAR PARK, Texas, Sept. 24, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline [...]
Eurobio Scientific: Results for the first semester of fiscal year 2026
24/09/2026
RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2026 Revenue up 4.5% to 84.5 M€ Proprietary products account for 37% of revenue 46% of revenue generated outside France Free cash flow of €4 million after investments Net [...]
Eurobio Scientific: Résultat du 1er semestre 2026
24/09/2026
RESULTAT DU 1 ER SEMESTRE 2026 Chiffre d’affaires en croissance de 4,5% à 84,5 M€ les produits propriétaires atteignent 37% du CA la part du CA hors France est de 46% Flux de trésorerie disponible de 4 M€ après [...]
SK pharmteco lance un kit de catalyseurs destiné à rationaliser le développement des réactions catalytiques et leur mise à l’échelle en fabrication continue
24/09/2026
Cette nouvelle offre structurée vise à assurer la continuité entre le criblage des catalyseurs, l’optimisation des procédés et la fabrication en flux continu à l’échelle commerciale pour les matières premières [...]
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
24/09/2026
SRX has added ONCO in anticipation of Realbotix LLC acquisition closing. Believes Vinci AI Vision system is extremely undervalued and misunderstood, with multiple potential applications in defense, ranging from drones [...]
Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio
24/09/2026
Velinotamig (BCMA TCE) multi-dose regimen data in SLE at ACR Convergence 2026 in November CLN-978 (CD19 TCE) multi-dose regimen data in SLE, RA and Sjögren’s disease in December CLN-049 (FLT3 TCE) updated data from the [...]
Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development
24/09/2026
FDA clearance expands development of forazapadin into a second degenerative muscle disease with significant unmet medical need FSHD Canada Foundation to provide up to US$5 million in non-dilutive financing toward the [...]
Atavistik Bio Announces Strategic Research Collaboration with Roche to Discover and Develop Novel Allosteric Therapeutics
24/09/2026
Collaboration leverages Atavistik Bio’s proprietary AMPS TM platform to identify and advance novel allosteric small molecules against multiple targets for cardiometabolic diseases Atavistik Bio to receive $70 million [...]

Pages